A Comparison of Two Type of Stems in Revision Hip Arthroplasty
Overview
This study compares two different hip stem components. Both hip stems used in this study allow the femur bone to attach and grow into them for stability. The main difference between the two stems is that one of the stems, the Solution® Stem, is made from Cobalt Chrome, a type of metal, and does not have a hydroxylapatite (HA) coating, while the second stem included in the study, the Restoration hip stem, is made from titanium alloy, a different type of metal that has a roughened surface and allows for a hydroxylapatite (HA) coating to be applied to the entire length of the stem. The HA coating is a thin calcium phosphate layer on the stem to encourage the bone to grow into it. We are trying to see if there is any difference in the initial bony ingrowth between the two stems and to compare the results in patients over the first two years after the surgery and then again at the five-year period.
Full Title of Study: “A Randomized Controlled Trial Comparing a Titanium to a Cobalt Chrome Femoral Stem in Revision Hip Arthroplasty: A Pilot Study”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Single (Participant)
- Study Primary Completion Date: September 2010
Detailed Description
Revision total hip arthroplasty is becoming increasingly common due to the large number of primary total hip arthroplasties being performed annually. Failure of these arthroplasties has led to an increasing number of patients requiring revision arthroplasty. Various methods have been used to reconstruct the hip during a revision procedure. These have generally consisted of a cemented or uncemented femoral stem. It is now generally accepted that uncemented femoral stems have improved results over cemented stems, especially in those cases with compromised bone stock. There are two main alloys used for the femoral revision component, that is cobalt chrome and titanium. There may be certain advantages to the use of titanium, in particular, a reduction in future bone loss caused by stress shielding. Stress shielding is commonly seen with cobalt chrome implants. In order to assess this and the overall survival of these two different implants a randomized clinical trial is proposed.
Interventions
- Procedure: Restoration HA stem
- The Restoration hip stem, is made from titanium alloy, a different type of metal that has a roughened surfacing and allows for a hydroxylapatite (HA) coating to be applied to the entire length of the stem.
- Procedure: Solution stem
- The Solution stem is made from Cobalt Chrome, a type of metal, and does not have a hydroxylapatite (HA) coating.
Arms, Groups and Cohorts
- Active Comparator: Restoration HA Stem
- The Restoration hip stem, is made from titanium alloy, a different type of metal that has a roughened surfacing and allows for a hydroxylapatite (HA) coating
- Sham Comparator: Solution stem
- The Solution stem is made from Cobalt Chrome, a type of metal, and does not have a hydroxylapatite (HA) coating.
Clinical Trial Outcome Measures
Primary Measures
- Safety of surgical implant
- Time Frame: 24 months
- Safety of surgical implant will be assessed by reviewing revision rates and complication rates post surgery
Secondary Measures
- Patient outcome measures
- Time Frame: pre-op, 6, 12, 24, 60 months
- Patient outcome measures will be assessed using the SF-12 and WOMAC questionnaires.
- Effectiveness of surgical implant
- Time Frame: 24 months
- The Harris Hip Score will be used to evaluate the effectiveness of the surgical implant
Participating in This Clinical Trial
Inclusion Criteria
- Candidates for revision hip arthropathy Exclusion Criteria:
- Under 21 years of age
Gender Eligibility: All
Minimum Age: 21 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Ottawa Hospital Research Institute
- Collaborator
- Stryker Nordic
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Paul R Kim, MD, FRCSC, Principal Investigator, OHRI
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.